Flash Finance

Arvee Laboratories (India) LimitedARVEECorporate

Chemicals Latest results: Mar 2026 6 quarters of data
Consolidated Standalone
₹226.20
MCap ₹249 Cr
Arvee Laboratories (India) Limited — Stock analysis & AI research Arvee Laboratories (India) Limited — Seasonality — best & worst months Arvee Laboratories (India) Limited — Technical setup — score, trend, support & resistance Arvee Laboratories (India) Limited — Live exchange announcements
🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹11 Cr
Sales · Mar 2026
₹1 Cr
Operating Profit · Mar 2026
10.2%
OPM % · Mar 2026
₹1 Cr
Net Profit · Mar 2026
₹0.47
EPS · Mar 2026

📝 Arvee Laboratories (India) Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Arvee Laboratories (India) Limited reported revenue of ₹11 crore for the quarter ended March 2026 (Q4 FY26), and up 10.5% sequentially over the December 2025 quarter.

Net profit stood at ₹1 crore. Earnings per share (EPS) came in at ₹0.47.

Operating profit stood at ₹1 crore — an operating margin (OPM) of 10.2%.

Full year and trailing twelve months

For the full year FY26, Arvee Laboratories (India) Limited posted revenue of ₹24 crore, with a net profit of ₹2 crore.

Valuation snapshot

At the current price of ₹226.20, ARVEE has a market capitalisation of ₹249 crore.

Within the Chemicals industry, it is the 25th-largest of the 79 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 73.50%, public shareholders 26.50% of Arvee Laboratories (India) Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹249 Cr
Current Price ?
₹226.2
P/E ?
N/A
Industry P/E ?
24.60
P/B ?
7.38
P/S ?
N/A
P/FCF ?
-84.50
Enterprise Value ?
₹250 Cr
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
N/A
Dividend Yield ?
N/A
Profitability & Returns
Sales (TTM) ?
N/A
OPM ?
N/A
Profit after tax (TTM) ?
N/A
EPS (TTM) ?
N/A
ROCE ?
7.9%
ROE ?
N/A
ROA ?
N/A
Growth
Sales — latest qtr ?
₹11 Cr
PAT — latest qtr ?
₹1 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
N/A
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹1 Cr
Debt to Equity ?
0.03
Interest Coverage ?
10.1
Current Ratio ?
N/A
Ownership
Promoter holding ?
73.50%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
43.2%
Return 6 months ?
35.1%

🗓️ Quarterly results (6 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Sep 2023Sep 2024Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 1391331011 — +10.5%
Operating Profit 112021 — -32.1%
Other Income 000000 — +7.2%
Interest 000000 — +24.1%
Depreciation 000000 — +3.6%
Profit Before Tax 101011 — -38.7%
Net Profit 001021 — -71.5%
EPS 0.01———1.660.47 — -71.7%
OPM % 9.2% 7.8% 12.0% 3.7% 16.6% 10.2% — -38.6%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric Prev FY FY26 TTM YoY %
Sales — ₹24 Cr — —
Operating Profit — ₹3 Cr — —
OPM % — 11.88% — —
NPM % — 9.81% — —
Other Income — ₹1 Cr — —
Depreciation — ₹1 Cr — —
Interest — ₹0 Cr — —
EBIT — ₹2 Cr — —
PBT — ₹2 Cr — —
Tax — ₹-0 Cr — —
Net Profit — ₹2 Cr — —
EPS — ₹2.13 — —
Material Cost — ₹13 Cr — —
Employee Cost — ₹3 Cr — —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 11.0211.0211.0211.02 +0.0%
Reserves 17.0418.0920.2422.77 +12.5%
Borrowings 1.001.001.031.11 +7.8%
Other Liabilities 9.638.455.298.36 +58.0%
Total Liabilities 38.6938.5637.5843.26 +15.1%
Fixed Assets 12.6812.6715.2716.72 +9.5%
CWIP 1.532.620.730.90 +23.3%
Investments 0.000.000.000.00 —
Other Assets 24.4823.2721.5825.64 +18.8%
Total Assets 38.6938.5637.5843.26 +15.1%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 2.933.66-0.21-0.12 +42.9%
Cash from Investing Activity -1.26-2.16-1.320.50 +137.9%
Cash from Financing Activity -2.42-0.19-0.12-0.16 -33.3%
Net Cash Flow -0.751.31-1.640.23 +114.0%
Free Cash Flow 1.471.07-2.06-2.95 -43.2%
CFO/OP 64%139%10%3% -70.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 72.9473.4879.66121.05 +52.0%
Inventory Days 42.29159.0280.31228.81 +184.9%
Days Payable 73.30164.4957.72158.60 +174.8%
Cash Conversion Cycle 41.9468.01102.25191.26 +87.1%
Working Capital Days 70.4495.97103.55166.92 +61.2%
ROCE % 23.34%6.83%9.58%7.92% -17.3%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 73.50%73.50%73.50%73.50%73.50% +0.0%
Public 26.50%26.50%26.50%26.50%26.50% +0.0%
No. of Shareholders 1,5051,5051,8611,6381,947 +18.9%

⚖️ Peer comparison

Industry: Chemicals · top 25 of 79 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 NAVINFLUOR Navin Fluorine ₹8,545.00 43,843 55.4 3,634 790 33.9% 21.7% 41.1% 130.1% 44.1% 107.7%
2 DEEPAKNTR Deepak Nitrite ₹1,596.00 21,768 27.8 8,575 784 15.5% 9.1% -4.8% -22.5% 36.4% 207.4%
3 DEEPAKFERT Deepak Fertilisers ₹1,323.00 16,718 17.0 12,103 985 16.7% 8.1% 12.0% -21.8% 22.5% 101.0%
4 TATACHEM Tata Chemicals ₹615.00 15,668 — 15,120 -1,971 11.3% -13.0% -2.0% -543.2% 14.4% -81.0%
5 PCBL PCBL Chemical ₹331.50 13,043 43.3 6,596 298 13.4% 4.5% -12.5% -46.0% 17.0% 64.8%
6 JUBLINGREA Jubilant Ingrevia ₹647.25 10,208 33.3 4,651 308 13.4% 6.6% 5.1% 10.3% 25.3% 40.9%
7 ALKYLAMINE Alkyl Amines ₹1,818.60 9,301 41.3 1,658 225 20.6% 13.5% -2.3% -3.8% 30.1% 93.1%
8 CLEAN Clean Science ₹820.00 8,715 37.4 982 232 35.7% 23.6% -2.5% -13.7% 21.9% -4.7%
9 GNFC Gujarat Narmada ₹539.75 7,931 7.6 8,410 1,037 14.8% 12.3% -1.5% 35.3% 39.8% 275.9%
10 GALAXYSURF Galaxy Surfactants ₹2,156.30 7,887 21.6 5,752 353 10.4% 6.1% 24.3% -50.0% 39.4% 108.7%
11 NEOGEN Neogen Chemicals ₹2,403.50 7,221 180.9 926 36 16.6% 3.8% 10.9% -17.6% 34.0% 66.8%
12 BALAMINES Balaji Amines ₹2,215.00 7,177 35.3 1,523 211 21.4% 13.9% 2.0% 6.5% 27.2% 113.9%
13 FCL Fineotex Chemical ₹53.07 6,180 41.6 1,012 148 16.7% 14.6% 44.8% 14.5% 174.8% 92.6%
14 ACI Archean Chemical ₹470.90 5,814 61.0 1,123 95 20.3% 8.5% 7.8% -37.0% 8.9% -24.4%
15 GULFOILLUB Gulf Oil ₹1,057.20 5,235 13.9 4,367 371 12.6% 8.5% 11.7% -3.4% 30.6% 27.0%
16 FOSECOIND Foseco India ₹6,846.50 5,186 64.7 618 77 17.5% 12.5% 12.2% -1.9% 9.2% 8.9%
17 GUJALKALI Gujarat Alkalies ₹696.50 5,115 77.0 4,497 66 11.2% 1.5% 7.0% 96.3% 12.6% 499.0%
18 LXCHEM Laxmi Organic ₹178.50 4,961 40.2 3,117 123 8.2% 4.0% -4.7% -43.4% 44.1% 194.8%
19 VISHNU Vishnu Chemicals ₹724.90 4,880 32.6 1,694 150 15.5% 8.8% 11.1% 12.2% 24.9% 23.0%
20 YASHO Yasho Industries ₹4,028.70 4,857 84.9 939 57 19.5% 6.1% 24.0% 771.1% 54.9% 801.3%
21 EPIGRAL Epigral ₹1,084.00 4,677 17.3 2,626 271 22.2% 10.3% -0.9% -7.2% 16.3% -37.9%
22 TATVA Tatva Chintan ₹1,867.60 4,369 85.0 556 51 19.3% 9.2% 32.6% 702.6% 42.8% 128.3%
23 GHCL GHCL ₹418.85 3,839 7.4 3,043 525 23.0% 17.3% -3.7% -23.5% -2.7% 31.8%
24 PREMEXPLN Premier Explosives ₹685.10 3,685 110.0 349 34 6.8% 9.6% -7.0% 60.5% -27.8% -80.2%
25 ARVEE Arvee Laboratories ₹175.20 193 47.6 41 4 13.0% 9.8% -18.1% 18.2% 130.3% 896.5%
❓ Frequently asked questions
What was Arvee Laboratories (India) Limited's revenue in Q4 FY26?
Arvee Laboratories (India) Limited reported revenue of ₹11 crore for the quarter ended March 2026 (Q4 FY26), and up 10.5% sequentially over the December 2025 quarter.
What was Arvee Laboratories (India) Limited's net profit in Q4 FY26?
Net profit stood at ₹1 crore. Earnings per share (EPS) came in at ₹0.47.
What is ARVEE's market capitalisation and P/E ratio?
At the current price of ₹226.20, ARVEE has a market capitalisation of ₹249 crore.
Who owns Arvee Laboratories (India) Limited? (shareholding pattern)
As of Sep 2026, promoters held 73.50%, public shareholders 26.50% of Arvee Laboratories (India) Limited.
TTM ends N/A. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI